| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 606985 | Camptothecin Derivative | 3.39349009784534e-005 | 0.7296169 |
| NSC 618939 | Camptothecin Derivative | 3.39349009784534e-005 | 0.74003236 |
| NSC 670664 | Null | 3.39349009784534e-005 | 0.27289548 |
| NSC 725774 | 6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride | 3.39349009784536e-005 | 0.72775074 |
| NSC 619003 | MX2 HCl | 4.54580437744686e-005 | 0.69015752 |
| NSC 628665 | Null | 4.54580437744686e-005 | 0.66828682 |
| NSC 744331 | (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd | 4.5458043774469e-005 | 0.43735532 |
| NSC 58239 | A 80021F34 | 4.88335076207314e-005 | 0.26817325 |
| NSC 166641 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 7-fluoro-2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride | 4.91939766674006e-005 | 0.47776905 |
| NSC 697685 | Null | 4.91939766674006e-005 | 0.56898369 |